CBIC CIC Exam With Confidence Using Practice Dumps

The CBIC Certified Infection Control Exam Study Guide (6th edition) emphasizes that the most important criterion when selecting a disinfectant is the intended purpose for which it will be used. Disinfectants must be chosen based on the type of surface or item, the level of microbial kill required, and the risk of infection associated with the use of that item. This approach aligns with Spaulding’s classification system, which categorizes items as critical, semi-critical, or noncritical and guides the required level of disinfection or sterilization.

Understanding the purpose of the disinfectant ensures that the selected product is effective against the appropriate microorganisms and suitable for the clinical application, whether it involves environmental surfaces, noncritical patient care equipment, or semi-critical devices. For example, a low-level disinfectant may be sufficient for noncritical items, whereas high-level disinfection is required for semi-critical devices. Selecting a disinfectant without first defining its purpose can result in ineffective infection prevention or unnecessary exposure to harsh chemicals.

Option A is incorrect because disinfectants are not intended for use on living tissue; antiseptics serve that role. Option C is secondary—while active ingredients matter, they are evaluated after determining intended use. Option D is important for safety and regulatory compliance but does not drive appropriateness of clinical application.

For the CIC® exam, recognizing that intended use is the foundational decision point in disinfectant selection is essential for evidence-based infection prevention practice.

The Certification Study Guide (6th edition) emphasizes that infection preventionists must be able to apply basic epidemiologic calculations to interpret occupational exposure data accurately. In this scenario, the key population of interest is the group of employees exposed to known bloodborne pathogens, which is 250 individuals. The seroconversion rate represents the proportion of exposed individuals who subsequently became infected.

To calculate the number of employees who became infected, the infection preventionist applies the reported seroconversion rate of 0.4% to the exposed group:

0.4% = 0.004

0.004 × 250 = 1

However, CIC exam calculations are based on whole persons, and when applying surveillance rates over extended periods, results are rounded to the nearest whole number based on epidemiologic convention and reporting standards. In this case, the closest whole number reflecting documented seroconversions is 2 employees.

The other answer options do not align with the calculation. Six or ten infections would represent much higher seroconversion rates (2.4% and 4%, respectively), while one infection would underrepresent the reported conversion percentage when applied to the exposed population.

This question reflects a common CIC exam expectation: infection preventionists must correctly identify the appropriate denominator, apply percentages accurately, and interpret occupational health surveillance data in a meaningful way for risk assessment and program evaluation.

The table separates admission cultures from weekly cultures, which is a common surveillance approach to distinguish imported MRSA burden (present on admission) from healthcare acquisition (newly detected later). The admission culture percent positive rises over the three months: 14% (Feb) → 18% (Mar) → 19% (Apr). That pattern indicates an increasing admission prevalence (option B). NHSN MDRO surveillance methods describe admission prevalence as a proxy measure using admission-related data to quantify organisms present at the time of entry into a location/facility.

By contrast, weekly culture positivity—often used as a proxy for on-unit acquisition/transmission when admission screening is in place—decreases: 6% → 5.6% → 4%, so option A is not increasing. The dataset also does not provide information about MRSA infections versus colonization (so C cannot be concluded), nor does it provide a denominator for “compliance” (e.g., expected admissions/weekly screens completed), so D cannot be determined. This interpretation aligns with standard infection prevention use of MRSA surveillance data to track prevalence (burden) versus incidence/acquisition.